AnalystsMatthew CaufieldMatthew Caufield's Stock Forecasts
AnalystsMatthew Caufield
Analyst Ranking
Bottom 1%
#4847 out of 4868 analysts
Average Return
-25.28%
Win Rate
28%35 out of 127
Risk vs Reward
Poor
Good
Matthew Caufield's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oyster Point Pharma IncOYST | +149.89% | $4.47 | $11.17 | 2022-07-17 - 2023-01-03 | Buy |
Iveric Bio IncISEE | +80.13% | $20.94 | $37.72 | 2022-11-03 - 2023-05-02 | Buy |
FabrinetFN | +77.99% | $153.66 | $273.50 | 2023-08-21 - 2024-08-21 | Buy |
Iveric Bio IncISEE | +71.85% | $21.95 | $37.72 | 2023-02-16 - 2023-05-02 | Buy |
4d Molecular Therapeutics IncFDMT | +71.62% | $18.36 | $31.51 | 2023-03-15 - 2024-03-15 | Buy |
Matthew Caufield Analyst Color
Get additional color on Matthew Caufield's coverage of popular stocks
Matthew Caufield's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Unity Biotechnology IncUBX | 8 | Buy | $4.00 | +253.98% | Reiterates | 8 days ago |
Lenz Therapeutics IncLENZ | 4 | Buy | $30.00 | +5.21% | Reiterates | 15 days ago |
Adverum Biotechnologies IncADVM | 5 | Buy | $30.00 | +820.25% | Reiterates | 15 days ago |
Immunic IncIMUX | 3 | Buy | $10.00 | +910.10% | Reiterates | 16 days ago |
Aldeyra Therapeutics IncALDX | 12 | Buy | $10.00 | +277.36% | Reiterates | a month ago |
Mineralys Therapeutics IncMLYS | 7 | Buy | $42.00 | +195.57% | Maintains | a month ago |
Surrozen IncSRZN | 2 | Buy | $32.00 | +190.64% | Reiterates | a month ago |
Fibrobiologics IncFBLG | 4 | Buy | $12.00 | +971.43% | Reiterates | a month ago |
Opus Genetics IncIRD | 12 | Buy | $8.00 | +742.11% | Reiterates | a month ago |
Hillevax IncHLVX | 5 | Hold | $2.00 | +3.09% | Reiterates | a month ago |
Kodiak Sciences IncKOD | 4 | Hold | $3.00 | -31.19% | Reiterates | a month ago |
Opthea LtdOPT | 7 | Hold | $2.00 | -41.35% | Downgrades | a month ago |
Eyenovia IncEYEN | 16 | Hold | $2.00 | +78.57% | Reiterates | a month ago |
Optinose IncOPTN | 7 | Hold | $9.00 | -3.43% | Downgrades | a month ago |
Diamedica Therapeutics IncDMAC | 4 | Buy | $10.00 | +140.96% | Maintains | a month ago |
Lyra Therapeutics IncLYRA | 6 | Hold | $2.00 | +1,580.67% | Reiterates | 2 months ago |
Zenas Biopharma IncZBIO | 2 | Buy | $30.00 | +159.07% | Reiterates | 2 months ago |
Phathom Pharmaceuticals IncPHAT | 8 | Buy | $28.00 | +552.68% | Reiterates | 2 months ago |
4d Molecular Therapeutics IncFDMT | 18 | Buy | $36.00 | +968.25% | Reiterates | 2 months ago |
FabrinetFN | 1 | Buy | $28.00 | N/A | Reiterates | 2 years ago |
Iveric Bio IncISEE | 6 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Oyster Point Pharma IncOYST | 1 | Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.